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Considering that the current immunoassays are not able to distinguish the infective
forms that cause Toxoplasma gondii infection, the present study was carried out
to evaluate the reactivity of two recombinant proteins (CCp5A and OWP1) from
oocyst/sporozoite, in order to differentiate infections occurring by ingestion of oocysts
or tissue cysts. The reactivity of the recombinant proteins was assessed against panels
of serum samples from animals (chickens, pigs, and mice) that were naturally or
experimentally infected by different infective stages of the parasite. Also, we tested
sera from humans who have been infected by oocysts during a well-characterized
toxoplasmosis outbreak, as well as sera from pregnant women tested IgM+/IgG+
for T. gondii, which source of infection was unknown. Only the sporozoite-specific
CCp5A protein was able to differentiate the parasite stage that infected chickens, pigs
and mice, with specific reactivity for oocyst-infected animals. Furthermore, the CCp5A
showed preferential reactivity for recent infection by oocyst/sporozoite in pigs and mice.
In humans, CCp5A showed higher reactivity with serum samples from the outbreak,
compared with serum from pregnant women. Altogether, these findings demonstrate the
usefulness of the CCp5A protein as a new tool to identify the parasite stage of T. gondii
infection, allowing its application for diagnosis and epidemiological investigations in
animals and humans. The identification of parasite infective stage can help to design
effective strategies to minimize severe complications in immunocompromised people
and, particularly, in pregnant women to prevent congenital infection.
Keywords: Toxoplasma gondii, oocyst-sporozoite antigen, molecular marker of infection, human toxoplasmosis,
animal toxoplasmosis, food security
INTRODUCTION
Toxoplasma gondii is an apicomplexan ubiquitary intracellular parasite that can infect all warm-
blooded animals, including humans (Tenter et al., 2000; Dubey et al., 2012; Franco et al., 2015).
The infection caused by this parasite is usually asymptomatic for immunocompetent individuals,
but it causes severe consequences for immunocompromised individuals, like HIV–AIDS patients.
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Also, when pregnant women acquire primary infection and
the parasite crosses the placental barrier, the fetus could be
severely aﬀected, which may lead to abortion, neonatal death, or
signiﬁcant postnatal complications (Halonen and Weiss, 2013).
The deﬁnitive hosts of this parasite are members of the
Felidae family, while the intermediate hosts are countless warm-
blooded animals. All three parasite stages are able to infect the
hosts: the bradyzoites present in tissue cysts, the sporozoites
contained in the oocysts and the tachyzoites (Innes, 2010). The
oral route is the most frequent form of postnatal transmission
of toxoplasmosis in humans. The infection can occur through
ingestion of infective oocysts shed with cat feces, which are
present in the environment, on vegetables, water and litter
boxes, or by ingestion of raw/undercooked meat (from pork,
lamb, chicken, or goat) containing tissue cysts. The prevalence
of infections is strictly related to cultural habits, food quality,
hygiene, and socio-economic status (Dubey, 1986, 2009; Aramini
et al., 1999; Bahia-Oliveira et al., 2003; Innes et al., 2009; Innes,
2010).
The oocyst stage of T. gondii is highly resistant to
disinfectants or freezing, although heat above 55◦C may kill
the sporozoites (Hill and Dubey, 2002; Schluter et al., 2014),
and contaminated drinking water sources may cause outbreaks
of toxoplasmosis worldwide. Thus, oocysts are considered an
important source of environmental contamination (Dubey, 2004;
Jones and Dubey, 2010). Until a few years ago, waterborne
toxoplasmosis had been considered rare, but this assertion
can be considered inappropriate nowadays, because there have
been several outbreaks in recent years linked to T. gondii
transmission by water (Dubey et al., 2012). In 1979, a
toxoplasmosis outbreak occurred among US military members,
who were doing training in Panama. It was attributed to the
water contaminated by feces from wild cats as the source
of infection, considering that the soldiers were fed only by
controlled foods (Sulzer et al., 1986). In 1995, an extensive
outbreak in Victoria, Canada, was connected to water infection
via oocyst (Bowie et al., 1997; Burnett et al., 1998). Since
1990, oocysts have been implicated as infective stage in
toxoplasmosis outbreaks in Brazil. In Santa Isabel do Ivaí,
from 426 individuals presenting anti-Toxoplasma IgM and IgG,
176 fulﬁlled the criteria to be deﬁned as cases, and 155 of
these patients showed symptoms of acute toxoplasmosis. In
this outbreak, the patients were infected by T. gondii oocysts
excreted by feces from domestic cats, which contaminated an
underground reservoir containing unﬁltered water (de Moura
et al., 2006).
In view of the great medical importance of toxoplasmosis,
many methods have been developed in the last decades to
improve the accuracy and sensitivity of serological assays.
Whole tachyzoite extracts have been used as antigen in various
protocols, resulting in signiﬁcant limitations for standardization
of the serological assays. For this reason, selected T. gondii
recombinant proteins have great potential as immunoreagents
(Beghetto et al., 2003; Buﬀolano et al., 2005; Kotresha and
Noordin, 2010; Hill et al., 2011; Santana et al., 2012).
The use of these proteins makes possible to design new
diagnostic tests based on well-characterized antigens. Additional
advantages include the relative low cost, high degree of purity,
and the possibility to select speciﬁc antigens for a given
infective stage of the parasite (Pietkiewicz et al., 2004, 2007;
Pfrepper et al., 2005; Kotresha and Noordin, 2010; Hill et al.,
2011).
Currently, there is no stage-speciﬁc serological assay for
toxoplasmosis to estimate the sources of infection worldwide.
The lack of this information hampers the accomplishment
of procedures to prevent and control T. gondii infection, as
the evidences of infection via oocyst is exclusively based on
epidemiological surveillance studies, which can be inaccurate
in many situations. These facts have also restricted the
implementation of educational programs to reduce or minimize
the risk factors associated with toxoplasmosis (Hill et al., 2011;
Munoz-Zanzi et al., 2012).
Recent proteomic studies have shed light on the repertoire
of proteins expressed by a so far poorly characterized stage
of T. gondii, the oocyst/sporozoite (Possenti et al., 2010, 2013;
Fritz et al., 2012a,b). Some of the stage-speciﬁc components
identiﬁed by this strategy can be considered as potential targets
for the development of novel diagnostic immunoassays able
to identify oocyst-driven infections. In this context, the major
aim of the present study was to assess the antigenic reactivity
of TgOWP1 and TgCCp5A, two polypeptides speciﬁcally
expressed by T. gondii oocysts or sporozoites, respectively.
Recombinant forms at these molecules were assayed, in
parallel with soluble tachyzoite antigen, against panels of
serum samples from the following hosts: chickens (naturally
infected by oocysts, experimentally immunized with tachyzoite
antigen, or experimentally infected with tissue cysts); pigs
(naturally infected or experimentally infected with oocysts
or tachyzoites); mice (experimentally infected with cysts or
oocysts); and humans (pregnant women positive for anti-
T. gondii IgM/IgG and individuals infected by oocysts during
an outbreak of toxoplasmosis). It was found that the CCp5A
recombinant polypeptide was able to eﬃciently diﬀerentiate
the parasite stage in infected chickens, pigs and mice, since
stage-speciﬁc antibodies were detected only in the sera from
oocyst-infected animals. In addition, human serum samples from
individuals who acquired infection by oocyst ingestion showed
higher IgM and IgG antibody levels to CCp5A in comparison
with serum samples from pregnant women. Together, these
ﬁndings indicate that CCp5A is a good molecular marker
to diﬀerentiate the T. gondii infective stages responsible for
infection.
MATERIALS AND METHODS
Study Approval
The maintenance and care of experimental animals complied
with the National Institutes of Health guidelines for the
human use of laboratory animals. The Ethics Committee
for Animal Experimentation from Federal University of
Uberlândia (CEUA-UFU) approved all procedures. Hens and
mice were maintained in individual cages at animal facilities
from this institution, and they received food and water ad
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libitum. Pigs were randomly allocated in separate stables
and all procedures involving these animals were approved
for the Ethics Committee for Animal Experimentation of
State University of Londrina, Paraná, Brazil. Concerning the
experiments analyzing human sera, the study was approved
by the Ethical Committee Involving Humans from the
State University of Londrina (CEP-UEL) and all patients
signed the consent term prior they have been enrolled in this
investigation.
Proteins
Soluble Toxoplasma Antigen (STAg)
Parasite suspensions from RH strain were adjusted
to 1 × 108 tachyzoites/ml and submitted to freeze-
thawing and sonication cycles in the presence of protease
inhibitors (Mineo et al., 1980; Marcolino et al., 2000). The
preparation was centrifuged at 10.000 × g for 15 min at
4◦C, and the supernatants were collected. Subsequently,
the protein content was determined (Bradford, 1976)
and aliquots of 100 ml were stored at −20◦C until being
tested.
Recombinant Proteins
Recombinant CCp5A andOWP1 possessing anN-terminal tail of
six histidines were produced according to the strategy described
previously (Possenti et al., 2010). Proteins were puriﬁed by nickel
aﬃnity chromatography and their contents quantiﬁed (Bradford,
1976). Aliquots of 100 µL were stored at −20◦C until being used.
The integrity of recombinant proteins and STAg were assessed by
electrophoresis on 12% minigels.
Serum Samples from Animals
Chicken Serum Samples
Chicken serum samples were obtained from animals naturally
infected by oocyst, experimentally immunized with STAg
or experimentally infected with tissue cyst. Serum samples
from naturally infected chickens were collected from chickens
raised extensively (n = 113) in various suburban areas from
Uberlândia city, MG, Brazil. Chickens raised extensively that
were seropositive to T. gondii were considered naturally
infected. For serum samples of animals that were experimentally
infected or immunized, hens of a commercial strain were
used. The hens were derived from chickens immunized
against the various pathogens, but they were seronegative to
T. gondii infection. Serum samples from chickens immunized
with STAg were collected after immunization of hens with
emulsion composed of STAg and Freund’s adjuvant by muscular
route. Primary immunization was performed with 100 µg
of STAg in 250 µL of PBS and equal volume of Freund’s
complete adjuvant (Sigma Chem, Co., St. Louis, MO, USA).
Two boosters were performed at 15-days intervals, with
100 µg of STAg plus Freund’s incomplete adjuvant, as
described elsewhere (Ferreira-Júnior et al., 2012). Serum
samples from experimentally infected chickens with cysts
were obtained after oral infection of hens with 100 cysts of
T. gondii (VEG strain), as previously described (Kaneto et al.,
1997).
Pig Serum Samples
Serum samples were obtained from three groups of pigs,
i.e., naturally infected by oocyst, experimentally infected with
tachyzoites or experimentally infected with oocysts. Samples
from naturally infected pigs were collected from 44 castrated
male pigs with the same genetic background. These animals
were weaned when they were 21-days-old and maintained at
Piracaíba farm, Araguari, MG, Brazil. For the serum samples
of animals that were experimentally infected, six mixed-breed
pigs from 6.5 to 7.5 weeks of age, including females and
castrated males, were randomly allocated in separate stables.
The animals were acclimatized for 6 days. All pigs were
seronegative to T. gondii until the day of infection. The pigs
were experimentally infected with 1 × 106 tachyzoites of RH
strain by intramuscular injection (n = 3) or by 1.5 × 104
oocysts of VEG strain by the oral route (n = 3), as previously
described (Garcia et al., 2005). Serum samples of these animals
were collected and analyzed on days 0, 7, 14, 21, and 28 post-
infection.
Mouse Serum Samples
Sera were obtained from mice experimentally infected with
T. gondii tissue cysts or oocysts. All experiments were carried
out with 8–12 weeks-old female Balb/c mice maintained under
standard conditions in the Bioterism Center and Animal
Experimentation, Federal University of Uberlândia, MG, Brazil.
Brieﬂy, two groups of ﬁve animals were infected with 50 oocysts
or 50 cysts of T. gondii (VEG strain) by oral route, as described
elsewhere (Hill et al., 2011). Serum samples were collected and
analyzed on days 0, 15, 30, 45, and 60 post-infection.
Human Serum Samples
Serum Samples from Outbreak
A total of 78 serum samples from a toxoplasmosis outbreak
was collected from individuals living in the municipalities
of Ouro Preto do Oeste, Jaru and Ji-Paraná in the state of
Rondônia, Brazil (Sociedade Brasileira de Parasitologia, 2011).
This well-documented toxoplasmosis outbreak occurred between
July and August from 2011 and the source of infection was
water containing T. gondii oocysts, due to an accident that
took place 3 weeks before, which contaminated the water
resources from the cities. All infected individuals started with
symptoms such as fever, prostration, muscle pain, joint and
head, onset of swelling in the lymph nodes, especially in the
neck region. Ocular disease was observed in some cases. All
samples were seropositive for T. gondii infection by commercial
immunoassays. The epidemiological investigations concluded
that the source of infection was water contaminated by
oocysts.
Pregnant Women
A total of 78 serum samples from pregnant women with IgM and
IgG against T. gondii was analyzed. These samples came from the
Outpatient Reference Centre for Pediatric Infectious Diseases,
which is the reference service for congenital toxoplasmosis at
the Outpatient Clinical Hospital, State University of Londrina,
Paraná State, Brazil.
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Western Blot Analysis
Electrophoretic Transfer
For Western blot analysis, 2 µg of each antigen (recombinant
proteins or STAg) in sample buﬀer (Tris-HCl 100 mM [pH
6.8]; 4% SDS; 20% glycerol, bromophenol blue 0.2%) were
incubated for 5 min at 100◦C and resolved by 12% SDS-
PAGE.After electrophoretic separation, proteins were transferred
to nitrocellulose membrane using electrotransfer system (Mini
Trans-Blot R© Eletrophoretic Transfer Cel, Bio-Rad, Hercules,
CA, USA). The nitrocellulose membranes were cut into
approximately 3 mm wide strips and placed in channels for the
reaction.
Immunoblotting of Serum Samples
Strips were blocked with PBS plus 0.05% Tween 20 (PBS-T)
supplemented with 5 or 8% skimmed milk for 2 h at room
temperature. After washing with PBS-T, the strips were incubated
for 18 h at 4◦C with serum samples from chickens, pigs or
mice, as described elsewhere (Dubey, 2010). After washing
with PBS-T, strips were incubated with secondary antibody
speciﬁc to each species conjugated to peroxidase (Sigma) for
2 h at room temperature. The membranes were washed again
with PBS-T and developed by adding 3,3′-diaminobenzidine
(DAB) at 1 mg/ml in 20 mM Tris-HCl (pH 7.2) and 0.03%
H2O2.
Enzyme-linked Immunosorbent Assay
The immunoenzymatic assays were carried out to detect antibody
reactivity against STAg or recombinant proteins in serum
samples from chickens, pigs, mice, and humans. Brieﬂy, high
aﬃnity polystyrene microtiter plates (Corning 3590 Laboratories,
Inc., New York, NY, USA) were coated with STAg (10 mg/ml)
or recombinant proteins (2 mg/ml) in carbonate-bicarbonate
buﬀer 0.06 M (pH 9.6) for 18 h at 4◦C. Plates were incubated
with serum samples and subsequently with secondary antibody
speciﬁc to each species conjugated to peroxidase (Sigma). The
assay was revealed by adding the enzyme substrate (0.03%
H2O2 and 2,2-azino-bis-3-ethyl-benzothiazoline sulfonic acid
[ABTS, Sigma] in 0.07 M citrate phosphate buﬀer, pH 4.2).
The cut oﬀ of the reaction was calculated as the mean OD of
negative control sera plus 3 standard deviations. The negative
control sera consisted of a pool of 10 serum samples tested
negative for T. gondii infection. Antibody titers were expressed
as ELISA index (EI), according to the following formula:
EI = OD sample/OD cut oﬀ, as previously described (Silva
et al., 2002). Samples with EI values ≥ 1.2 were considered
positive.
Statistics
Statistical analyses were performed using the GraphPad Prism v.
5.0 (GraphPad Software, San Diego, CA, USA). Antibody levels
were compared between the recombinant proteins and STAg
using one-way ANOVAwith Bonferroni post-test. Student’s t-test
was used to assess diﬀerences in the antibody kinetics analyses.
Positivity rates for antigen preparations were analyzed by Fisher
exact test. Values of P < 0.05 were considered statistically
signiﬁcant.
RESULTS
Serologic Differentiation of T. gondii
Stages in Chicken Infections
In order to identify a T. gondii protein potentially able to
diﬀerentiate infections driven by distinct parasite infective stages,
it was analyzed serum samples from chickens by Western blot
analysis on the selected T. gondii proteins. It was included
recombinant polypeptides belonging to distinct parasite proteins
whose expression suggested an oocyst/sporozoite-speciﬁc proﬁle,
as determined by proteomic analyses reported in the ToxoDB
database. Chicken sera were assessed against the recombinant
polypeptides in comparison with STAg. When serum samples
from diﬀerent group of chickens were tested against the
recombinant antigens, a diﬀerential reactivity was observed for
CCp5A and OWP1 polypeptides (Figure 1A). Both proteins were
recognized exclusively by sera from naturally infected chickens,
with the CCp5A protein fragment showing the highest reactivity
among all analyzed recombinant proteins.
To conﬁrm whether the recombinant fragments from CCp5A
and OWP1 could work as serological markers of infection via
oocysts, it was performed an ELISA against the recombinant
proteins in comparison with STAg, using 113 individual sera from
free-range chickens. The levels of IgY antibodies were expressed
by ELISA index (EI) for each antigen. The STAg reactivity showed
an EI mean of 1.7, as compared to CCp5A and OWP1, which
displayed EI means of 1.7 and 2.0, respectively (Figure 1B). The
positivity rates were 80% for STAg, 70% for CCp5A, and 74% for
OWP1 (Figure 1C). Based on these results, CCp5A and OWP1
showed characteristics of oocyst markers for chicken infection.
Serologic Differentiation of T. gondii
Stages in Pig Infections
To distinguish sources of T. gondii infection in pigs, it was
assessed the recombinant proteins analyzed for chicken serum
samples. As shown in Figure 2A, CCp5A showed exclusive
reactivity for serum samples from pigs infected by oocysts,
whereas OWP1 showed no reactivity for all serum samples
analyzed. As expected, the STAg antigen presented reactivity for
all serum samples, no matter the source of infection. As only
recombinant CCp5A was able to diﬀerentiate the infective stages
in pigs, it was used this antigen to evaluate its performance in
the kinetics of IgG production in pigs experimentally infected
by either oocysts or tachyzoites. Serum samples were collected
on days 0, 7, 14, and 28 post-infection and analyzed by ELISA.
As shown in Figure 2B, the kinetics of IgG to CCp5A in serum
samples from pigs infected with oocysts showed increasing levels
until day 7 post-infection (EI = 1.6). After this time point,
it was observed a slight decline until day 28 post-infection
(EI = 1.3). In contrast, when analyzing the kinetics of IgG
to CCp5A in serum samples from tachyzoite-infected pigs, EI
mean values were below the cut oﬀ (EI = 1.2) for all time
points analyzed (Figure 2C). Also, signiﬁcant diﬀerences between
the sources of infection were observed on day 7 and 14 post-
infection, with detection of higher levels in serum samples from
pigs infected with oocysts, in comparison with serum samples
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FIGURE 1 | Serologic analysis of chicken sera using oocyst/sporozoite-specific proteins of Toxoplasma gondii. (A) Two recombinant proteins from
T. gondii oocyst/sporozoite (CCp5A and OWP1) and whole tachyzoite soluble antigen (STAg) were tested by Western blot using serum samples from chickens
immunized with STAg (left panel), experimentally infected with T. gondii tissue cysts (central panel) or naturally infected by oocysts (right panel). The arrowheads
indicate the detected protein bands and the molecular weight markers (MW) are represented in kDa at the left side of left panel. Levels of IgY antibodies (B) and
positivity (C) were evaluated using ELISA in serum samples from free range chickens collected in suburban areas of Uberlândia, MG, Brazil (n = 113). The results
were expressed as ELISA index (EI) and values higher than 1.2 were considered positive. The dashed line indicates the cut off of the reactions. Significant differences
among IgY levels against recombinant proteins and STAg were determined by one-way ANOVA, while the differences among positivity rates were evaluated using
Fisher’s exact test.
from pigs infected with tachyzoites. The early detection of
anti-CCp5A IgG in pigs infected with oocysts suggested that
this recombinant polypeptide might be considered a serological
marker of recent oocyst-driven Toxoplasma infection in pigs.
The production of IgG against STAg in serum samples from
oocyst-infected pigs raised at day 7 post-infection and increased
at all time points (Figure 2C), showing highest levels on day
28 post-infection (EI = 6.8). Similarly, the kinetics assay for IgG
to STAg in serum samples from pigs experimentally infected
with tachyzoites increased over time with highest levels on
day 28 post-infection (EI = 4.5; Figure 2C). Unlike oocyst-
driven infection, positive EI values were observed only from
day 14 onward. Signiﬁcant diﬀerences between oocyst and
tachyzoite as sources of infection were observed for all time
points analyzed, with higher levels for serum samples infected by
oocysts (P < 0.0001).
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FIGURE 2 | Detection of anti-Toxoplasma antibodies in pig sera using the oocyst/sporozoite-specific protein CCp5A. (A) The recombinant proteins
CCp5A and OWP and STAg were tested by Western blot using serum samples from pigs experimentally infected with oocysts or tachyzoites. The arrowhead
indicates the detected protein band and the molecular weight markers (MW) are represented in kDa at the left side of left panel. Kinetics of IgG production to T. gondii
determined by ELISA using recombinant CCp5A (B) or STAg (C) in sera from pigs experimentally infected with oocysts (blank squares) or tachyzoites (black circles).
(D) Levels of IgG antibodies and positivity rates were evaluated using ELISA in serum samples from free range pigs created in Piracaíba farm in Araguari, MG, Brazil.
The results were expressed as ELISA index (EI) and values higher than 1.2 were considered positive. The dashed line indicates the cut off of the reactions. Significant
differences between sources of infection were determined by the Student’s t-test for each time point or Fisher’s exact test to compare positivity rates. ∗P < 0.05.
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In order to assess the diagnostic value of the CCp5A
recombinant polypeptide in a population of naturally infected
pigs, serum samples from animals raised extensively (n = 44)
were tested against CCp5A and STAg by ELISA. As shown in
Figure 2D, 100% of positivity was observed for both antigenic
preparations and no signiﬁcant diﬀerence was observed in
the levels of IgG antibodies between CCp5A and STAg. The
seropositivity against CCp5A strongly suggests the oocysts as the
probable source of infection in naturally infected pigs.
Serologic Differentiation of T. gondii
Stages Involved in Mouse Infections
In order to assess the stage-speciﬁcity of the humoral response
directed against CCp5A in a more controlled animal model,
Balb/c mice were infected by oocysts or tissue cysts. As
shown in Figure 3A, Western blot analysis revealed that
CCp5A is exclusively recognized by serum samples from
oocyst-infected mice, whereas STAg showed reactivity to serum
samples from both oocyst- and cyst-infected mice. In agreement
with the ﬁndings observed in pigs, these results conﬁrm the
ability of CCp5A to diﬀerentiate T. gondii stages responsible
for the infection. Aiming to further evaluate the serological
characteristics of CCp5A in comparison with STAg, kinetics
assays for both IgM and IgG isotypes were carried out, using
serum samples from mice infected by oocysts. As shown in
Figures 3B,C, the kinetics of IgM synthesis toward CCp5A and
STAg presented diﬀerent proﬁles. Interestingly, the kinetics of
IgM for CCp5A showed a peak at day 15 post-infection (EI= 2.0),
followed by a marked drop of the antibody titer reaching values
below the cut oﬀ at day 45 post-infection (EI = 1.1). Signiﬁcant
diﬀerences between day 0 and day15 (P < 0.0001) and day 0 and
day 30 (P < 0.05) were observed. In contrast, IgM antibodies to
STAg was found to increase over time, and the highest levels were
reached at day 60 post-infection. Signiﬁcant diﬀerences between
day 0 and all other post-infection time points were observed
(P< 0.0001). The kinetics of anti-CCp5A IgG production showed
that the antibody titer increased over time, reaching a peak on day
45 (EI = 3.7). From day 45 post-infection, a slight decrease was
observed until day 60 post-infection (EI = 3.1; Figure 3D). The
kinetics of anti-STAg IgG showed that this isotype level increased
over time, reaching a peak at day 60 post-infection (EI = 7.8;
Figure 3E). Signiﬁcant diﬀerences between day 0 and other time
points were observed (P < 0.05; P < 0.0001). The kinetics of
IgM production against CCp5A points out to this protein as a
parasite component associated with an early stage of infection in
oocyst-infected mice.
Evaluation of CCp5A as a Serologic
Marker in Human Sera
As the CCp5A polypeptide resulted a stage-speciﬁc serological
marker of infection in the animal species, the next step
was to evaluate its performance with two diﬀerent panels of
human serum samples, in comparison with STAg. As shown
in Figure 4A, the levels of IgM antibodies against CCp5A
polypeptide were higher in serum samples from patients involved
in toxoplasmosis outbreak (EI = 1.6), when compared with sera
from pregnant women (EI = 1.0; P < 0.0001). Interesting, the
IgM positivity rate of serum samples from the toxoplasmosis
outbreak (80%) was markedly higher, when compared with
serum samples from pregnant women (16%; P < 0.0001). We
also evaluated the IgM levels and positivity rates to STAg. As
shown in Figure 4B, the levels of IgM were signiﬁcantly higher
in serum samples from the outbreak (EI = 4.6), when compared
with sera from pregnant women (EI= 1.4; P< 0.0001). However,
it was observed no signiﬁcant diﬀerence between the positivity
rates of sera from the outbreak (92%) and pregnant women
(76%). Next, it was evaluated the IgG levels and reactivity to the
CCp5A recombinant fragment (Figure 4C). As observed for IgM,
the IgG antibody levels were higher in serum samples from the
outbreak (EI = 2.4), when compared with serum samples from
pregnant women (EI = 1.2). Signiﬁcant diﬀerence between the
positivity rate of outbreak (82%) and pregnant women (52%)
serum samples was observed (P < 0.001). In contrast, the
analysis of IgG antibodies to STAg demonstrates higher levels
of antibodies in sera from pregnant women (EI = 6.6), when
compared with serum from the Toxoplasma outbreak (EI = 4.4),
as shown in Figure 4D (P < 0.0001). The positivity rates for
both groups of sera were 100%. Overall, these results suggest
that CCp5A is able to detect both IgM and IgG antibodies in
human sera from patients who have been infected by T. gondii
oocysts. Additionally, it was observed that in serum samples from
pregnant women with serological evidence of recent exposure to
the parasite, anti-CCp5A IgM antibodies were detected in 80% of
samples, indicating a high prevalence of oocyst-driven infection.
DISCUSSION
Toxoplasmosis has emerged as a waterborne disease of
signiﬁcant medical importance, considering its probability
to cause outbreaks, with serious consequences even for
immunocompetent people, who may develop severe ocular
disease (Aramini et al., 1998, 1999; Burnett et al., 1998; Dubey,
2004). In these situations, oocysts shed by feces from felids, either
from urban or rural areas, can contaminate water reservoirs
and infect humans and domestic animals (Aramini et al., 1999;
de Moura et al., 2006; Schluter et al., 2014). The clinical
importance of toxoplasmosis and the possibility of causing
outbreaks worldwide has led to its classiﬁcation as Category B
priority agent by The National Institute of Allergy and Infectious
Diseases (NIAID; Kim and Weiss, 2008).
Previous studies have shown that, in intermediate hosts, the
infection by oocysts is considered clinically more severe when
compared to infections caused by cysts (Dubey, 2004). These
ﬁndings are reinforced by the fact that many cases of human
infections caused by oocysts exhibit clinical symptoms, even in
immunocompetent individuals (Montoya and Liesenfeld, 2004;
Innes, 2010). In addition to these relevant outcomes, oocysts
are able to contaminate the environment as shown by serologic
surveys conducted on herbivorous animals and vegetarian people
(Rawal, 1959; Dubey, 2010; Ahmad and Qayyum, 2014). Taking
into account the central role of oocysts in the T. gondii
transmission, the identiﬁcation of proteins that are expressed
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FIGURE 3 | Detection of anti-Toxoplasma antibodies in mouse sera using the oocyst/sporozoite-specific protein CCp5A. (A) The CCp5A recombinant
protein and STAg were tested by Western blot using serum samples from mice experimentally infected with T. gondii oocysts or tissue cysts. The arrowhead
indicated the detected protein bands and the molecular weight markers (MW) are represented in kDa at the left side of left panel. Kinetics of IgM (B,C) or IgG (D,E)
production to recombinant CCp5A (B,D) or STAg (C,E) were determined by ELISA in sera from mice experimentally infected with oocysts at different time points
after infection. The results were expressed as ELISA index (EI) and values higher than 1.2 were considered positive. Dashed line indicates the cut off of the reaction.
Significant differences between day 0 and other time points were determined by paired Student’s t-test in each time point. ∗P < 0.05; ∗∗∗P < 0.0001.
exclusively by oocysts/sporozoites may help to reveal parasite
targets for the development of novel stage-speciﬁc serologic
assays (Fritz et al., 2012b; Possenti et al., 2013).
The search for speciﬁc proteins from T. gondii
oocysts/sporozoites has been investigated since the 80s
(Kasper and Ware, 1985; Kasper, 1989), but only recently
oocyst/sporozoite-speciﬁc proteins have been characterized
with potential use in vaccine design and diagnosis (Radke et al.,
2004; Possenti et al., 2010; Boyer et al., 2011; Hill et al., 2011;
Doskaya et al., 2014). In the present study, it was investigated
the serologic application of T. gondii polypeptides speciﬁc from
oocysts/sporozoites by using reference serum samples from
animals (chickens, pigs, and mouse) and humans, in order to
determine which parasite stage was involved in the infection.
First, the entire panel of recombinant proteins was tested against
sera from chickens, naturally infected by oocysts, experimentally
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FIGURE 4 | Reactivity of recombinant CCp5A with human sera from a toxoplasmosis outbreak. Recombinant CCp5A was used to screen human sera from
patients involved in a waterborne toxoplasmosis outbreak or from pregnant women with anti-T. gondii IgG antibodies. The levels of IgM (A,B) of IgG (C,D) to
recombinant CCp5A (A,C) or STAg (B,D) were evaluated by ELISA. The results were expressed as ELISA index (EI) and values higher than 1.2 were considered
positive. Dashed line indicates the cut off of the reactions. Significant differences among serum samples levels were determined by Student’s t-test. ∗∗∗P < 0.0001.
infected with tissue cysts, or experimentally immunized with
tachyzoite antigen. Based on the results obtained by Western
blot and ELISA, the proteins CCp5A and OWP1 were selected
to be further analyzed by ELISA against 113 serum samples from
naturally infected chickens. These proteins showed ability to
detect antibodies preferentially in sera from animals infected by
T. gondii oocysts, reinforcing the results obtained by Western
blot. High positivity rates of naturally infected chicken sera
were found for CCp5A (70%), and OWP1 (74%), demonstrating
the high level of environmental contamination with oocysts in
the region. To our knowledge, this is the ﬁrst work using sera
from hens in order to diﬀerentiate infective stages of T. gondii.
Moreover, the majority of studies performed to analyze antibody
response in chickens against T. gondii used total antigens of the
parasite (Zhu et al., 2008; Barakat et al., 2012; Zhao et al., 2012).
It was described in the literature just a single work evaluating
the use of recombinant proteins from T. gondii oocysts against
serum samples from chickens (Hotop et al., 2014). However,
the authors only evaluated the correlation between the immune
response toward those recombinant proteins and the dose of
oocysts experimentally inoculated in chickens. In contrast,
our study focused on the identiﬁcation of the parasite stage
responsible for infection, indicating that recombinant CCp5A
and OWP1 showed predominant reactivity with sera from
chickens infected by oocysts. Next, we probed the recombinant
proteins CCp5A and OWP1 with sera from pigs in order to
assess the ability to diﬀerentiate the infective forms of T. gondii
in a mammalian model that is known to be a signiﬁcant source of
Toxoplasma infections in humans (Dubey, 2009; Schluter et al.,
2014). Only CCp5A showed reactivity with serum samples from
experimentally infected pigs. The lack of reactivity of OWP1
with serum samples from pigs may be due to diﬀerences in the
immune system of mammals and birds (Sharma and Tizard,
1984; Butler et al., 2009). Thus, our data indicate that CCp5A
may be used to identify sera from chickens and pigs infected with
oocysts.
When the kinetics of IgG in serum samples from pigs infected
with oocysts was analyzed, the CCp5A protein showed higher
reactivity to this antibody isotype at day 7 post-infection. From
this early phase onward, the kinetics assays showed a tendency
to decrease over the time. On the other hand, the kinetics assays
for IgG detection to CCp5A in serum samples from animals
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infected with tachyzoites showed no reactivity, as all EI values
were below the cut oﬀ at all time points. These results strengthen
the speciﬁcity of CCp5A to detect anti-Toxoplasma antibodies in
pigs infected with oocysts and indicate that it could be considered
a molecular marker for acute phase of infection. In contrast, the
IgG kinetics to STAg increased over time for sera from animals
experimentally infected by oocysts or tachyzoites. Taken into
account that these diﬀerences in the kinetics of IgG production
are likely due to the type of infective stage, the early detection
of IgG against CCp5A observed in our study might be due
to the expression of this protein only by sporozoites, whose
stage-speciﬁc antigens are exposed to the host immune system
exclusively at the beginning of the infection (Dubey et al., 1998).
Accordingly, CCp5A, which contains a LCCL domain (Trexler
et al., 2000), a common feature of various secreted proteins
among apicomplexan parasites (Tosini et al., 2006), including
T. gondii, is expressed only in the oocyst stage (Fritz et al.,
2012a). It was described in the literature that a recombinant
protein from T. gondii sporozoites (TgERP) is able to diﬀerentiate
infection by cysts or oocysts in serum samples from pigs by
Western blot (Hill et al., 2011). It was observed that this antigen
preparation was able to selectively detect the presence of speciﬁc
antibodies to TgERP in pigs infected with oocysts until 6–
8months after infection In our work, however, the highest level of
anti-CCp5A IgG antibodies in oocyst-infected pigs was detected
at day 7 post-infection, followed by a gradual decrease until day
28. These observations conﬁrm the importance of the antigenic
preparations to evaluate antibody kinetics, particularly whether
they are prepared from sporozoite, bradyzoite, or tachyzoite
parasites. In addition, our data showed 100% of positivity to
CCp5A and STAg in samples from pigs raised extensively,
resulting in naturally infected animals and indicating that the
causative agent was the oocyst and suggesting a high level of
environmental contamination by oocysts on the farm, where
they had been raised. Similar results were observed using the
TgERP protein in pig samples from slaughterhouses in Chile
(80% of positivity; Munoz-Zanzi et al., 2012). These observations
show the impact of the environmental contamination by oocysts
in infected animals, which are used as food resources for
humans, making clear that the identiﬁcation of the infective form
responsible for the infection is important.
The reactivity of CCp5A protein assessed in the mouse model
was conﬁrmed with sera from animals infected with oocysts, as
a strong staining by Western blot was observed in the present
study. The kinetics approaches for IgM and IgG antibodies to
STAg in mice infected with oocysts revealed increasing levels
over time. In contrast, the kinetics of IgM and IgG antibodies
to CCp5A presented diﬀerent proﬁles, with IgG antibodies to
CCp5A reaching the highest level at 45 days after infection. As
noticed for the kinetics of IgG antibodies in pigs infected with
oocysts, the kinetics of anti-CCp5A IgM production in mice
showed an early peak of reactivity, at day 15 post-infection. In
agreementwith our results, a previous study assessing the kinetics
of mouse IgM antibodies against a recombinant protein from
T. gondii sporozoites (SporoSAG), showed a peak of reactivity
from 10 to 15 days post-infection in mice infected with oocysts
(Doskaya et al., 2014), reinforcing the hypothesis that the use of
proteins expressed exclusively by oocysts/sporozoites is critical to
identify the early phase of oocyst-driven T. gondii infection.
A major obstacle to carry out procedures against
toxoplasmosis in humans is the lack of information concerning
the infective form of T. gondii responsible for the infection in
a given population. In order to overcome this diﬃculty, we
have selected the CCp5A protein by screening panels of serum
samples from various intermediate hosts, including a panel
of human sera. This latter came from patients involved in a
toxoplasmosis outbreak, which epidemiological investigations
revealed that the aﬀected individuals were likely infected by
ingestion of oocysts in water. Also, this panel included serum
samples from pregnant women showing positivity for IgM
and IgG antibodies to T. gondii, but whose source of infection
was unknown. When these serum samples were assessed for
IgM antibodies against STAg, no signiﬁcant diﬀerences were
observed in the percentages of positivity between both groups
(92% for outbreak-related sera and 76% for serum samples
from pregnant women), although the reactivity levels were
higher in serum samples from the outbreak. For IgG antibodies,
the percentage of positivity was 100% for both groups of
infected individuals, being these results in accordance with
those observed for animal sera (chickens, pigs, and mouse),
in which the STAg could not diﬀerentiate the infective forms
of the parasite. However, when we screened for IgM and IgG
directed to CCp5A, it was observed higher antibody levels
and positivity rates in serum samples from the outbreak, as
compared with samples from pregnant women. When analyzing
the IgM antibodies, it was observed that 80% of the serum
samples showed reactivity to CCp5A, whereas only 16% of
sera from pregnant women were positive. These results suggest
that the majority of the patients from the outbreak, who were
presenting clinical manifestations of acute infection, were
actually infected by oocysts, supporting the hypothesis that
CCp5A shows characteristics of a molecular marker for recent
infection by T. gondii. When it was compared the percentage
of IgM positivity between STAg (76%) and CCp5A (16%) in
serum samples from pregnant women, a signiﬁcant diﬀerence
could be conﬁrmed. This diﬀerence may be due to the fact that
STAg presents a mixture of various proteins, which may lead
to detection of IgM antibodies beyond the acute phase. On the
other hand, the lower detection of anti-CCp5A IgM observed in
serum samples from pregnant women infected by an unknown
parasite stage, can be explained by the fact that a single protein
was employed. The use of a single, well-deﬁned antigen like
CCp5A can reduce the frequency of false positive results, which
are frequently observed in conventional immunoassays. For
IgG analysis, 82% of outbreak serum samples were positive for
CCp5A, while 52% of pregnant women sera were positive. These
results indicate that the majority of the outbreak serum samples
came from patients that were actually infected by oocysts, while
18% of serum samples came from patients infected by other
parasite stages. The serologic analysis of sera from pregnant
women showed that 52% of samples reacted with CCp5A. These
results indicate that pregnant women in this population might be
infected by oocysts or tissue cysts with equal probability, showing
the importance to prevent the infection during pregnancy not
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only by avoiding the ingestion of undercooked meat, but also
preventing contact with oocysts present the environment.
In a previous study using the recombinant protein from
sporozoite (TgERP) against human serum samples infected with
oocysts, Hill et al. (2011) evaluated 17 serum samples infected
by oocysts, being six samples from laboratory employees that
were accidentally exposed to oocysts and 11 serum samples from
outbreak of toxoplasmosis. All six infected individuals presented
IgM and IgG antibodies to TgERP and 9 out of 11 (82%)
individuals infected with oocysts had detectable antibodies to
TgERP. These results are in agreement with the present study,
although we have used a higher number of serum samples from
outbreak to observe our results.
In summary, we have demonstrated that CCp5A is a
new serologic tool capable to identify oocysts/sporozoites
as the causative agent for T. gondii infection. This parasite
sporozoite-speciﬁc protein can be considered a new molecular
marker to be used in diagnosis and epidemiological studies
in order to identify the source of infection for animals
and humans. The identiﬁcation of the infective stage of
T. gondii responsible for the infection can help to design
eﬀective strategies to minimize parasite transmission and to
prevent severe complications, mainly in immunocompromised
people and pregnant women. Furthermore, these ﬁndings
contribute to identify the source and parasite stage
responsible for T. gondii infection in cases of toxoplasmosis
outbreaks. Future studies should be done to evaluate the
immunogenic ability of the CCp5A protein in vaccination
protocols.
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